The Uromigos

401 Episodes

1. Episode 343: ESMO 2024 - TiNivo-2 Trial

   Published: 9/14/2024
2. Episode 342: ESMO 2024 Preview with Silke Gillessen

   Published: 9/3/2024
3. Episode 341: Hormone Resistance in Prostate Cancer

   Published: 8/27/2024
4. Episode 340: Cancer Immunity Cycle Update

   Published: 8/19/2024
5. Episode 339: Tres Uramigas analizan lineamientos de ESMO para GU

   Published: 8/9/2024
6. Episode 338: RCC: Debulking Nephrectomy, Adjuvant Therapy Future and More

   Published: 8/6/2024
7. Episode 337: Updated NCCN Guidelines in RCC

   Published: 7/30/2024
8. Episode 336: Which patients are not suitable for 1st line EVP in bladder cancer

   Published: 7/24/2024
9. Episode 335: Novel immune therapies for renal cancer

   Published: 7/19/2024
10. Episodio 334 en español: Tres Uramigas ASCO 2024

    Published: 7/11/2024
11. Episode 333: The Uromigos Cup - The Netherlands

    Published: 7/5/2024
12. Episode 332: The Uromigos Cup - Germany's Entry

    Published: 6/26/2024
13. Episode 331: AUA 2024 NMIBC Highlights

    Published: 6/21/2024
14. Episode 330: ASCO 2024 Highlights

    Published: 6/10/2024
15. Episode 329: Japan in the Uromigos Cup qualifying round

    Published: 6/7/2024
16. Episode 328 ASCO24: Emergency podcast - what the NADINA trial means for preoperative GU cancer studies

    Published: 6/5/2024
17. Episode 327 ASCO24: CM901 and EV302 Efficacy and QOL Updates

    Published: 6/4/2024
18. Episode 326 ASCO24: KIM-1 in Renal Cancer

    Published: 6/3/2024
19. Episode 325 ASCO24: KN426 and the CLEAR trial - tissue based biomarkers for kidney cancer

    Published: 6/3/2024
20. Episode 324 ASCO24: SURE1 neoadjuvant sacituzumab govitecan in UC

    Published: 6/2/2024